Promoting Cancer Screening Among Medicaid Recipients in Minnesota
NCT ID: NCT03275987
Last Updated: 2017-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
138554 participants
INTERVENTIONAL
2014-04-23
2017-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Trial Evaluating the Effectiveness of the General Practitioner Involvement in Cancer Screening Invitations
NCT02367001
Primary Care Based Randomized Trial to Reduce Cancer Screening Disparities
NCT00818857
Behavioral Economic Approaches to Increase Colorectal Cancer Screening
NCT02660671
Rural Interventions for Screening Effectiveness
NCT02795104
Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print
NCT01072851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To determine the efficacy of the interventions we used a two group posttest-only randomized design with all eligible MA beneficiaries randomly assigned to one of two groups: Direct Mail plus Incentive (with patient navigation) versus usual care.
The primary outcomes were completion of mammography or colonoscopy within 12 weeks after implementation of the intervention. Current Procedural Technology (CPT) codes from Medicaid claims data were used to determine if an individual had received either mammography or colonoscopy. Specific CPT codes used for mammography were conventional mammography (77055-77057), digital mammography (G0202, G0204, G0206), and computer-aided detection mammography (77051, 77052). CPT codes used for colonoscopy were G0105, G0121, 45378, and 45380-45385. Mammography and colonoscopy outcomes were measured dichotomously. Outcomes were based on the presence of screening mammography and colonoscopy claims occurring for 10 weeks after the first mailings.
The mammography and colonoscopy interventions were examined separately. Across treatment and control, study sample characteristics were compared and absolute differences were assessed using t-test and χ2 statistics. Main outcome analyses consisted of logistic regression to compute odds ratios for receiving mammography or colonoscopy and for covariate adjustment. Two separate logistic regression models were examined for both mammography and colonoscopy interventions: (1) a bivariate model that examined treatment versus control, and 2) a multivariate model that adjusted for covariates. All analyses were conducted using Stata, version 13.
Some individuals lost Medicaid coverage on a monthly basis during the study period, and others had inaccurate mailing addresses (\< 2% of each study sample). Therefore not everyone received the treatment as intended, and individuals that received the intervention may not have had Medicaid claims available post-intervention. Our outcome analyses were intent-to-treat analyses that included all individuals randomized to treatment or control groups at initiation of intervention regardless of whether they lost coverage post-randomization or if they had an inaccurate mailing address.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mammography treatment
Mammography direct mail coupled with a financial incentive
Mammography direct mail coupled with a financial incentive
The intervention groups received innovative and persuasive direct mail materials coupled with an incentive for using their Medicaid benefit to get screened.
Mammography control/delayed intervention
Usual care (for 15 months); Mammography direct mail coupled with financial incentive (after 15 months)
Mammography direct mail coupled with a financial incentive
The intervention groups received innovative and persuasive direct mail materials coupled with an incentive for using their Medicaid benefit to get screened.
Usual care
Group received usual care, and direct mail 15 months after treatment group received intervention.
Colonoscopy treatment
Colonoscopy direct mail coupled with a financial incentive
Colonoscopy direct mail coupled with a financial incentive
The intervention groups received innovative and persuasive direct mail materials coupled with an incentive for using their Medicaid benefit to get screened.
Colonoscopy control/delayed intervention
Usual care (for 15 months); Colonoscopy direct mail coupled with financial incentive (after 15 months)
Usual care
Group received usual care, and direct mail 15 months after treatment group received intervention.
Colonoscopy direct mail coupled with a financial incentive
The intervention groups received innovative and persuasive direct mail materials coupled with an incentive for using their Medicaid benefit to get screened.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mammography direct mail coupled with a financial incentive
The intervention groups received innovative and persuasive direct mail materials coupled with an incentive for using their Medicaid benefit to get screened.
Usual care
Group received usual care, and direct mail 15 months after treatment group received intervention.
Colonoscopy direct mail coupled with a financial incentive
The intervention groups received innovative and persuasive direct mail materials coupled with an incentive for using their Medicaid benefit to get screened.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Women having mammogram in 15 months before trial (mammography intervention)
* Evidence of a colonoscopy in the past 10 years, flexible sigmoidoscopy in the past five years, or fecal immunochemical or fecal occult blood test in the past year (colonoscopy intervention)
50 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minnesota Department of Health
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan Slater
Chief of Cancer Control Section
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan S Slater, PhD
Role: PRINCIPAL_INVESTIGATOR
Minnesota Department of Health
Christina L Nelson, MS
Role: STUDY_DIRECTOR
Minnesota Department of Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minnesota Department of Health
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Innovations2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.